RMFEX
Price
$54.47
Change
-$1.82 (-3.23%)
Updated
Apr 3 closing price
Net Assets
102.75B
SDIVX
Price
$27.23
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Net Assets
N/A
Ad is loading...

RMFEX vs SDIVX

Header iconRMFEX vs SDIVX Comparison
Open Charts RMFEX vs SDIVXBanner chart's image
American Funds American Mutual R4
Price$54.47
Change-$1.82 (-3.23%)
VolumeN/A
Net Assets102.75B
Stock Dividend
Price$27.23
Change-$0.00 (-0.00%)
VolumeN/A
Net AssetsN/A
RMFEX vs SDIVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFEX vs. SDIVX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a StrongBuy and SDIVX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SDIVX pays higher dividends than RMFEX: SDIVX (4.15) vs RMFEX (1.61). RMFEX was incepted earlier than SDIVX: RMFEX (23 years) vs SDIVX (20 years). SDIVX (0.85) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. SDIVX (3.74). RMFEX has a lower initial minimum investment than SDIVX: RMFEX (250) vs SDIVX (100000). SDIVX annual gain was more profitable for investors over the last year : 12.95 vs. RMFEX (7.10). RMFEX return over 5 years is better than : 78.86 vs. SDIVX (68.26).
RMFEXSDIVXRMFEX / SDIVX
Total Expense Ratio0.620.8573%
Annual Report Gross Expense Ratio0.620.8573%
Fund Existence23 years20 years-
Gain YTD2.8917.28940%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets103BN/A-
Annual Yield % from dividends1.614.1539%
Returns for 1 year7.1012.9555%
Returns for 3 years12.516.63189%
Returns for 5 years78.8668.26116%
Returns for 10 years70.9952.96134%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMMEX15.19N/A
N/A
Northern Active M Emerging Market Equity
GMXAX15.20N/A
N/A
Nationwide Mid Cap Market Idx A
MSVVX11.99N/A
N/A
Mesirow Small Company Investor
MVISX39.40N/A
N/A
Patient Opportunity IS
JHDAX18.20N/A
N/A
JPMorgan Hedged Equity 2 A